Manish A. Shah, MD, discusses the 5-year outcomes from the phase 3 KEYNOTE-590 study of first-line pembrolizumab plus chemotherapy in patients with advanced esophageal cancer.
In the days leading up to the anniversary of Aretha Franklin’s death, two of her doctors spoke out about how the late singer handled her cancer diagnosis.